Latest filing published 14 Aug 2026 for Supernus Pharmaceuticals, INC.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Padmanabh P. Bhatt is a declared insider of Supernus Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 32 filings, for trades running from 15 July 2022 to 12 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 14 August 2026, the filings show an option exercise in Supernus Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 32 declarations